Breaking newsCOVID-19Research
N-terminal domain antigenic mapping reveals a site of vulnerability for SARS-CoV-2
N-terminal domain antigenic mapping reveals a site of vulnerability for SARS-CoV-2
We are extremely proud to announce that the EAN Congress has been named Best Corporate Event Subject to a Fee for the second consecutive year at the Evento Awards in Finland.
Latest Posts
-
-
Breaking newsCOVID-19Research
Neutralizing and protective human monoclonal antibodies recognizing the N-terminal domain of the SARS-CoV-2 spike protein
Neutralizing and protective human monoclonal antibodies recognizing the N-terminal domain of the SARS-CoV-2 spike protein -
Breaking newsCOVID-19Research
Antiviral drug screen identifies DNA-damage response inhibitor as potent blocker of SARS-CoV-2 replication
Antiviral drug screen identifies DNA-damage response inhibitor as potent blocker of SARS-CoV-2 replication -
Breaking newsCOVID-19Research
A single intranasal dose of chimpanzee adenovirus-vectored vaccine protects against SARS-CoV-2 infection in rhesus macaques
A single intranasal dose of chimpanzee adenovirus-vectored vaccine protects against SARS-CoV-2 infection in rhesus macaques -
Breaking newsCOVID-19ResearchEmergence of a SARS-CoV-2 variant of concern with mutations in spike glycoprotein
Emergence of a SARS-CoV-2 variant of concern with mutations in spike glycoprotein -
The first 12 months of COVID-19: a timeline of immunological insights -
Breaking newsCOVID-19Research
The serotonin reuptake inhibitor Fluoxetine inhibits SARS-CoV-2 in human lung tissue
The serotonin reuptake inhibitor Fluoxetine inhibits SARS-CoV-2 in human lung tissue -
Clofazimine broadly inhibits coronaviruses including SARS-CoV-2
-
Breaking newsCOVID-19Research
A conserved immunogenic and vulnerable site on the coronavirus spike protein delineated by cross-reactive monoclonal antibodies
A conserved immunogenic and vulnerable site on the coronavirus spike protein delineated by cross-reactive monoclonal antibodies -
Breaking newsCOVID-19ResearchNeurologic involvement in children and adolescents hospitalized in the United States for COVID-19 or multisystem inflammatory syndrome
Neurologic involvement in children and adolescents hospitalized in the United States for COVID-19 or multisystem inflammatory syndrome -
Breaking newsCOVID-19Research
Characteristics and outcomes of US children and adolescents with multisystem inflammatory syndrome in children (MIS-C) compared with severe acute COVID-19
Characteristics and outcomes of US children and adolescents with multisystem inflammatory syndrome in children (MIS-C) compared with severe acute COVID-19 -
Immunogenicity of the Ad26.COV2.S vaccine for COVID-19 -
Breaking newsCOVID-19Research
Association of clinical, biological, and brain magnetic resonance imaging findings with electroencephalographic findings for patients with COVID-19
Association of clinical, biological, and brain magnetic resonance imaging findings with electroencephalographic findings for patients with COVID-19 -
Breaking newsCOVID-19Research
Four-month clinical status of a cohort of patients after hospitalization for COVID-19
Four-month clinical status of a cohort of patients after hospitalization for COVID-19 -
Breaking newsCOVID-19Research
EEG Abnormalities are Common in COVID-19 and are Associated with Outcomes
EEG Abnormalities are Common in COVID-19 and are Associated with Outcomes